SCHEMBL4357462

SCHEMBL4357462

[NH]NC(=O)c1ccc(C(F)(F)F)cc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AVPR2 P30518 1/20 0.50
GPR27 Q9NS67 1/20 0.50
MAPT P10636 3/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 1/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
KMT2A Q03164 1/20 0.48
SORT1 Q99523 1/20 0.48
TMPRSS4 Q9NRS4 4/20 0.47
JAK2 O60674 1/20 0.47
JAK1 P23458 1/20 0.47
TYK2 P29597 1/20 0.47
CES2 O00748 2/20 0.46
TRPV1 Q8NER1 1/20 0.46
KDM4E B2RXH2 2/20 0.45
P2RX1 P51575 2/20 0.44
P2RX4 Q99571 2/20 0.44
P2RX7 Q99572 2/20 0.44
PPARD Q03181 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4352363 0.87 JAK2 (0.61) ALDH1A1MEN1LMNAKMT2ASORT1
SCHEMBL21434759 0.83 MAPT (0.62) AVPR2GPR27MAPTALDH1A1MEN1
SCHEMBL1818435 0.79 KDM4E (0.62) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL1455625 0.79 CES2 (0.52) AVPR2GPR27MAPTALDH1A1SORT1
SCHEMBL11503421 0.78 SCN9A (0.56) AVPR2GPR27SMOFLT1FLT4
SCHEMBL393739 0.78 KDM4E (0.69) MAPTALDH1A1MEN1LMNAKMT2A
SCHEMBL8617573 0.77 KDM4E (0.61) AVPR2GPR27ALDH1A1MEN1KMT2A
SCHEMBL30482175 0.77 PDE2A (0.50) AVPR2GPR27MAPTALDH1A1HTT
SCHEMBL6495907 0.77 PDE2A (0.50) AVPR2GPR27MAPTALDH1A1HTT
SCHEMBL6553697 0.77 KDM4E (0.61) AVPR2GPR27ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 AVPR2 646/4885GPR27 1716/4885MAPT 1470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.